Professor David Livermore
Professor Livermore brings a wealth of knowledge and expertise to the Company, with over 35 years in the sector and a long track record of research and publications on the evolution and epidemiology of antibiotic resistance, particularly β-lactamases. Currently Professor of Medical Microbiology at the University of East Anglia (UEA), he serves on the UK Government’s Antimicrobial Resistance & Healthcare Associated Infection Advisory Committee, and has contributed extensively to the Chief Medical Officer for England’s 2011 Annual Report. Prior to this he spent 14 years with the Public Health Laboratory Service (now Public Health England), becoming Director of its Antibiotic Resistance Monitoring and Reference Laboratory. Within his current UEA role, he continues to provide sessions to Public Health England as its Lead on Antibiotic Resistance. In his earlier career, Professor Livermore spent 17 years at the London Hospital Medical College. He has edited for several journals, presently including the International Journal of Antimicrobial Agents. David has a PhD in Medical Microbiology from the University of London. He consults widely for the pharmaceutical industry.